Effect of ginsenoside Rh-2 via activation of caspase-3 and Bcl-2-insensitive pathway in ovarian cancer cells
Language English Country Czech Republic Media print
Document type Journal Article
PubMed
27959575
DOI
10.33549/physiolres.933367
PII: 933367
Knihovny.cz E-resources
- MeSH
- Enzyme Activation drug effects MeSH
- Apoptosis drug effects MeSH
- Epithelial-Mesenchymal Transition drug effects MeSH
- Ginsenosides pharmacology MeSH
- Wound Healing drug effects MeSH
- Caspase 3 drug effects metabolism MeSH
- Humans MeSH
- Cell Line, Tumor MeSH
- Ovarian Neoplasms metabolism MeSH
- Cell Proliferation drug effects MeSH
- Proto-Oncogene Proteins c-bcl-2 drug effects metabolism MeSH
- Signal Transduction drug effects MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- BCL2 protein, human MeSH Browser
- CASP3 protein, human MeSH Browser
- ginsenoside Rh2 MeSH Browser
- Ginsenosides MeSH
- Caspase 3 MeSH
- Proto-Oncogene Proteins c-bcl-2 MeSH
Ginsenoside has been reported to have therapeutic effects for some types of cancer, but its effect on ovarian cancer cells has not been evaluated. In this study, we monitored the effects of ginsenoside-Rh2 (Rh2) on the inhibition of cell proliferation and the apoptotic process in the ovarian cancer cell line SKOV3 using an MTT assay and TUNEL assay. We found that Rh2 inhibited cell proliferation and significantly induced apoptosis. We confirmed the apoptotic effects of Rh2 using western blot analysis of apoptosis-related proteins. Specifically, the levels of cleaved poly ADP ribose polymerase (PARP) and cleaved caspase-3 significantly increased in SKOV3 cells treated with Rh2. Therefore, Rh2 clearly suppressed the growth of SKOV3 cells in vitro, which was associated with induction of the apoptosis pathway. Moreover, the migration assay showed that Rh2 inhibited the invasive ability of SKOV3 cells. Taken together, our results suggest that Rh2 has anticancer effects in SKOV3 cells through inhibition of cell proliferation and induction of apoptosis. Considering the therapeutic potential of Rh2, more studies should be carried out to facilitate the future application of this natural product as a potential anti-cancer agent.
References provided by Crossref.org